![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Glanbia Plc | LSE:GLB | London | Ordinary Share | IE0000669501 | ORD EUR0.06 (CDI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 18.20 | 17.30 | 19.10 | 239 | 08:01:32 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 5.43B | 344.5M | 1.2652 | 14.39 | 4.96B |
RNS Number:3060S Glanbia PLC 20 November 2003 Change in Executive Director responsibilities Glanbia plc wishes to announce that Mr Kevin Toland, an Executive Director of the company, has been given responsibility for Group Strategy and Development. As Group Development Director, Mr. Toland will continue to have responsibility for Glanbia Foods UK Ltd. and Glanbia Cheese Ltd. Arising from this appointment, Mr. Pat Brophy, currently CEO of Glanbia Dairies in Ireland, has been given responsibility for Irish consumer operations and has been appointed to the Group Executive. ENDS 20 November 2003 Enquiries to: Michael Patten Group Director of Communications, Glanbia plc. Tel: 056-7772357 / 087-2414502 This information is provided by RNS The company news service from the London Stock Exchange END BOAEAAFEASDDFFE
1 Year Glanbia Chart |
1 Month Glanbia Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions